AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

MedPage Today published a weekly collection of comments from clinicians and researchers on developments across medicine. The remarks covered dengue outbreaks, pregnancy exposure to dupilumab, multiple sclerosis diagnosis, menopause symptoms, advance care planning and a small psilocybin study in Parkinson’s disease.

MedPage Today published a weekly roundup on October 25 featuring comments from physicians and researchers on recent health reports, including dengue outbreaks, medication exposure during pregnancy and early research involving psilocybin. The collection highlights several developments but does not itself establish new clinical findings; the underlying evidence varies from a meta-analysis and a small trial to individual case reports.

Before you orderOffer from Amazon

Get health and wellness essentials delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Adam Waickman, a researcher at SUNY Upstate Medical University, said, “The cat is out of the bag” while discussing large dengue outbreaks in Florida and warning of possible further spread in the United States. The roundup provides no outbreak figures or specific forecast, so the remark is a warning rather than a quantified assessment of future cases.

Other comments addressed questions about dupilumab (Dupixent) exposure during pregnancy and children’s later health. Christina Chambers of the University of California San Diego said it remains “an open question” whether early-life exposure could reduce a child’s long-term risk of atopic conditions. The source says available data indicated exposure in pregnancy appeared safe, but the roundup does not provide study details or establish a long-term preventive effect.

The roundup also covered an incorrect multiple sclerosis diagnosis discussed by Cleveland Clinic neurologist Marisa McGinley; an exceptionally rare infant case in which a second colon was later identified; and a meta-analysis on non-hormonal menopause drugs and sleep disturbances. Other items concerned a video tool that increased documentation of advance care planning in patients nearing kidney failure and a small Parkinson’s disease trial linking psilocybin with lower markers of systemic inflammation and mitochondrial stress.

At a glance
recapWhen: Published October 25, 2026
The developmentMedPage Today published its October 25, 2026, roundup of notable comments from health professionals on recent medical reports and cases.

Signals Across Several Medical Fields

The roundup draws attention to developments with different levels of evidence and different implications. The dengue warning concerns potential public-health spread, while the dupilumab question is about a possible long-term outcome that researchers have not resolved. The menopause meta-analysis and advance-care-planning research may inform ongoing clinical discussions, but the brief source does not provide enough detail to judge the size or durability of the reported effects.

The distinction matters for readers: a notable quotation is not a substitute for the underlying study, and preliminary research does not establish a treatment recommendation. In particular, the psilocybin finding came from a small trial and concerned biological markers, not proof of clinical benefit for Parkinson’s symptoms. The collection serves as a guide to topics under discussion, rather than a single unified finding.

Products Worth Considering

Garmin Forerunner 265 GPS Running Smartwatch, 46 mm, Black/Powder Gray

Garmin Forerunner 265 GPS Running Smartwatch, 46 mm, Black/Powder Gray

As an affiliate, we earn on qualifying purchases.

Seven Topics Behind the Quotes

MedPage Today’s feature is a recurring roundup of quotations heard by its reporters. This edition brings together comments connected to separate news items and research reports, rather than reporting one shared event or policy change. Its subjects range from infectious disease and pregnancy to diagnosis, menopause care, planning for serious illness and experimental research.

The source attributes each comment to a named health professional and gives an affiliation. It does not include full study citations, participant counts, methods or detailed results for most items. Readers seeking to evaluate a particular claim would need the original report or research paper. The available material supports reporting that these subjects were discussed and that the speakers made the quoted remarks; it does not support adding specific statistics or conclusions not included in the roundup.

““This is good news for women.””

— JoAnn Manson, MD, MPH, DrPH, Harvard Medical School

Evidence and Open Questions

The roundup does not give the full methods, sample sizes or effect estimates for the studies it mentions. It is not clear how large or geographically extensive the Florida dengue outbreaks were, what evidence supports the warning of further U.S. spread, or what timeline that warning refers to. Nor does the source specify how pregnancy exposure to dupilumab was assessed or whether long-term outcomes in exposed children have been studied.

Other details are also limited. The meta-analysis findings are not accompanied by the medicines reviewed or the magnitude of changes in sleep. The advance-care-planning item does not state how many patients took part or how much documentation increased. For the psilocybin trial, the roundup does not provide the trial size, duration or whether changes in biological markers were associated with changes in symptoms. These points remain unanswered in the supplied report.

Follow the Underlying Studies

The next step for readers is to consult the original reports and studies for the evidence behind each quotation, including the designs, populations and measured outcomes. The source material does not announce a specific follow-up date, new policy or scheduled research milestone. Further information about dengue surveillance, longer-term outcomes after dupilumab exposure and larger or later-stage trials may clarify the questions raised, but the roundup does not say when such updates will be available.

Key Questions

What is the news in this roundup?

MedPage Today published a collection of comments from health professionals on several recent medical reports and cases. It is a weekly recap, not a single new clinical study.

Did the report confirm that dengue will spread across the United States?

No. Adam Waickman warned about possible further spread while discussing outbreaks in Florida, but the supplied roundup gives no forecast, case figures or confirmation of spread to other states.

Does the roundup show that dupilumab prevents atopic conditions in children?

No. Christina Chambers described that possibility as an open question. The roundup says pregnancy exposure appeared safe in the data discussed, but it does not establish a long-term protective effect.

What did the psilocybin research find?

The roundup describes a small trial that linked psilocybin with reduced markers of systemic inflammation and mitochondrial stress in people with Parkinson’s disease. It does not report that the treatment improved symptoms or establish clinical effectiveness.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

市药检院举办“扬帆远航,一路有我” 政府开放月活动2026-08-12 – 上海市人民政府

Shanghai’s Municipal Drug Inspection Institute launches the ‘Sailing Forward, Together’ open month event to strengthen government-public engagement and promote drug safety.

Sanford Bemidji Surges In Global Coverage

Sanford Bemidji hospital experiences a surge in international media mentions, with GDELT reporting 20 times its usual coverage in recent hours.

Sight Sciences Surges In Global Coverage

Sight Sciences experiences a surge in worldwide coverage, with 25 mentions in recent media analysis, signaling increased industry interest.

Ballad Health Surges In Global Coverage

Ballad Health experiences a surge in international coverage, with 14 mentions in recent reports, marking increased global interest in the healthcare provider.